PCK
Click for more information
0.00% 3.2¢ painchek ltd

Health Metrics, page-21

  1. cal50
    7,134 Posts.
    lightbulb Created with Sketch. 385
    clock Created with Sketch.
    03/04/18
    18:48
    Post #: 32193682
    With the potential of PCK it should be 15 -20c let alone once any contracts get signed or get pushed into Europe and then the USA and China etc markets and then the baby app gets released . IMO we are no where near overvalued PCK is just getting started
    PCK Price at posting: 6.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch. 4  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $52.39M
Open High Low Value Volume
3.2¢ 3.2¢ 3.2¢ $715 22.33K

Buyers (Bids)

No. Vol. Price($)
1 2 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 260287 3
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.